Know Cancer

or
forgot password

The Role of IMP3 Expression in Patients With Neuroblastoma


N/A
N/A
18 Years
Not Enrolling
Both
Neuroblastoma

Thank you

Trial Information

The Role of IMP3 Expression in Patients With Neuroblastoma


Inclusion Criteria:



- Neuroblastoma patients with complete follow-up and sufficient samples for study.

Exclusion Criteria:

- Neuroblastoma patients without complete follow-up

- Neuroblastoma patients without sufficient samples for study.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Principal Investigator

Wen-Ming Hsu, M.D, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Taiwan University Hospital

Authority:

Taiwan: Department of Health

Study ID:

201002039R

NCT ID:

NCT01121419

Start Date:

January 2008

Completion Date:

January 2009

Related Keywords:

  • Neuroblastoma
  • Neuroblastoma
  • IMP3
  • Prognosis
  • Neuroblastoma

Name

Location